[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT07560306
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Cardiac Amyloidosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- [64Cu]FBP8 PET/MR — DRUGSimultaneous cardiac PET/MR images will be obtained following injection of \[64Cu\]FBP8.
Study Details
The primary goal of this pilot study is to determine whether \[64Cu\]FBP8, a novel fibrin-binding positron emission tomography (PET) probe, can identify intracardiac thrombi when paired with simultaneous hybrid cardiac PET/MRI in twenty (20) individuals with transthyretin or light chain cardiac amyloidosis and atrial fibrillation (AF) or atrial flutter (AF). The primary hypothesis of this study is that \[64Cu\]FBP8 PET/MRI can identify intracardiac thrombi in \>90% of subjects with confirmed intracardiac thrombi based on transesophageal echocardiogram (TEE). In secondary analyses, the investigators will seek to determine associations between intracardiac thrombi and left atrial function and left ventricular amyloid burden.
Key Dates
- Start date
- May 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 30, 2027
- Completion
- Mar 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: [64Cu]FBP8 PET/MR Cardiac Amyloid and Atrial Fibrillation/Atrial Flutter SubjectsIndividuals with documented cardiac amyloidosis and atrial fibrillation/atrial flutter will undergo \[64Cu\]FBP8 PET/MR.
Primary Outcome Measure
Intracardiac Thrombus [ Time Frame: 1 day ]
Central Contacts
- Vicente Morales Oyarvide, MD, MPH6172335860
- Sharmila Dorbala, MD, MPH617-732-6290
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Sharmila Dorbala, MD, MPH (PRINCIPAL_INVESTIGATOR) Vicente Morales Oyarvide, MD, MPH (SUB_INVESTIGATOR) Ciprian Catana, MD (SUB_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac AmyloidosisRecruiting · Columbia University · Beverly Hills, California
- US Benchmarking Clinical StudyRecruiting · eMyosound SAS · Boston, Massachusetts
- PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 LevelsNot Yet Recruiting · Lorena Saelices · Boston, Massachusetts
- N-of-1 for Beta-Blockers in Cardiac AmyloidosisPHASE4 · Enrolling By Invitation · Weill Medical College of Cornell University · New York, New York